#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neoplasm Adenoid cystic carcinoma Follicular lymphoma stage I SAPHO syndrome Mitochondrial myopathy Andersen-Tawil syndrome Leukodystrophy Epstein-Barr virus associated lymphoproliferative disorder Gastric cancer Malignant oligodendroglioma Extra-osseous Ewing's sarcoma recurrent Thrombocytosis Hyperadrenocorticism Atypical haemolytic uraemic syndrome Leukocyte adhesion deficiency type I More trials…

    Learn about Rare Diseases

    Basal cell naevus syndrome Niemann-Pick disease – Basic Information Lymphatic malformation Ewing’s sarcoma metastatic – Life with Disease Tuberous sclerosis complex – Basic Information Lymphangiosarcoma – Trials in Disease Glomerulonephritis membranous – Diagnostics Kearns-Sayre syndrome – Life with Disease Pleural mesothelioma malignant – Trials in Disease Hyperoxaluria – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Bromocriptine Hydroxychloroquine Sulfate Sapropterin Dihydrochloride Belumosudil Mesilate Oxacillin GSKVX000000025896 Mbs2320 Azacitidine Mirtazapine Pemetrexed Disodium Monalizumab S230815-2 Nadunolimab Sufentanil Fentanyl Vibegron Pozelimab Erenumab Ammonium Chloride AZD1163 More therapies…

    Learn about Your Condition

    Alveolar bone defect Diabetic gastroparesis Mucous membrane pemphigoid Oral lichen planus Metastasis Ureteric cancer Vascular graft thrombosis Overweight Primary hyperaldosteronism Uveitis Post procedural swelling Hypertrophic cardiomyopathy Malignant mast cell neoplasm Nocturia Uterine leiomyoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Non-Hodgkin’s lymphoma

  • Study on the Effectiveness of Entrectinib and Other Drug Combinations for Patients with Advanced Solid Tumors, Multiple Myeloma, or Non-Hodgkin Lymphoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Prolymphocytic leukaemia
    • Non-Hodgkin’s lymphoma
    • Plasma cell myeloma
    Investigated Drugs:
    • Dabrafenib
    • Dacomitinib
    • Erdafitinib
    The Netherlands

  • Study on Lymphoblastic Lymphoma Treatment in Children and Adolescents Using Dexamethasone, Prednisone, and PEG-Asparaginase

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-Hodgkin’s lymphoma
    Investigated Drugs:
    • Dexamethasone Acetate
    • Ifosfamide
    • Vindesine Sulfate
    Austria Belgium Czechia Denmark Finland Germany +8

  • Study on Preventing Hypothyroidism in Patients with Medulloblastoma and Pediatric Lymphoma Using Levothyroxine During Radiation Therapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Medulloblastoma
    • Hodgkin’s disease
    • Non-Hodgkin’s lymphoma
    Investigated Drugs:
    • Levothyroxine
    Italy

  • Study on Human Normal Immunoglobulin and Sodium Chloride to Prevent Infections in Patients with Chronic Lymphocytic Leukemia

    Recruiting

    3 1 1
    Investigated Diseases:
    • Non-Hodgkin’s lymphoma
    • Chronic lymphocytic leukaemia
    • Plasma cell myeloma
    Investigated Drugs:
    • Human Normal Immunoglobulin
    • Sodium Chloride
    Bulgaria Croatia Hungary Poland Romania

  • Phase 1/2 Study Evaluating Safety and Activity of GSK5926371 in Adults with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Non-Hodgkin’s lymphoma
    Finland France Italy

  • Study of [90Y]Y-PentixaTher and [68Ga]Ga-PentixaFor in patients with advanced Non-Hodgkin lymphomas: Evaluating radiopeptide-based imaging and therapy

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Non-Hodgkin’s lymphoma
    Investigated Drugs:
    • Pentixafor
    • Pentixather
    • Gallium (68Ga)
    Germany
Previous Page
1 2 3 4
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!